Probiotics and prebiotics may improve insomnia through gut-microbiota changes

In human trials, interventions significantly improved subjective sleep metrics measured by standard questionnaires (Pittsburgh Sleep Quality Index, Insomnia Severity Index), and some newer findings showed improvements in deep-sleep latency with yeast mannan supplementation. Dietary patterns like the MIND diet and Traditional Chinese Medicine decoctions enriched beneficial bacteria such as Bacteroides coprophilus and increased short-chain fatty acid production—compounds thought to support the gut-brain connection. Animal models demonstrated that specific "psychobiotic" bacterial strains (Bifidobacterium breve, Lacticaseibacillus paracasei) and prebiotics restored balance in sleep-regulating neurotransmitters (GABA and serotonin), lowered morning cortisol, and improved sleep architecture. However, the review identifies critical limitations: human studies relied heavily on self-reported sleep quality rather than objective measurements, follow-up periods were short (limiting insight into long-term effects), and a substantial gap exists between how these interventions work in rodent models versus humans. The evidence suggests these natural approaches may be viable, but current proof remains incomplete.

The review identifies two classes of bacteria as particularly promising: Bifidobacterium breve and Lacticaseibacillus paracasei (formerly Lactobacillus paracasei), which animal studies show restore GABA and serotonin—the brain's main sleep-promoting neurotransmitters. Prebiotics like galacto-oligosaccharides (GOS) and polydextrose (PDX) work by feeding these beneficial bacteria, increasing production of short-chain fatty acids (butyrate, propionate, acetate) that cross the blood-brain barrier and influence sleep-wake cycles. Yeast mannan showed a specific effect: it reduced the time needed to enter deep (N3) sleep. Traditional Chinese Medicine decoctions demonstrated efficacy in enriching Bacteroides coprophilus and lowering morning cortisol—a key stress hormone that disrupts sleep. The major caveat: animal models show these mechanisms clearly, but human trials measure only what subjects report about sleep, not objective brain activity or actual sleep architecture. Most studies lasted 4–12 weeks; no data exists on whether benefits persist beyond that window or whether people develop tolerance.